Principal Investigator
Jaime Merchan
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250949
Clinical Trial Summary
A Phase 1, Multicenter, Open-Label, Dose Escalation,
Dose Expansion and Dose Optimization Study of
BHV-1530 as Monotherapy and in Combination with Other Anti-Cancer Agents in Adult Participants with Advanced or
Metastatic Solid Tumors
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
+1 (407) 7659589